EUS-FNA demonstrated PC. We provided genetic counseling and performed BRCA genetic testing, which revealed a heterozygous, deleterious mutation [NM_000059.4(BRCA2): c.9076C > T(p.Gln3026Ter)]. This evidence concerns the gene BRCA2 and pachyonychia congenita.